Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai
Định dạng:	Bài viết
Ngôn ngữ:	English
Được phát hành:	Taylor & Francis Group 2019-06-01
Loạt:	CNS Oncology
Những chủ đề:	bevacizumab glioblastoma glioma long term progression recurrence
Truy cập trực tuyến:	https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Những quyển sách tương tự

Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab
Bằng: Alissa Thomas, et al.
Được phát hành: (2018-01-01)

A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumab
Bằng: Josie Hayes, et al.
Được phát hành: (2016-10-01)

A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults
Bằng: Patrick Roth, et al.
Được phát hành: (2020-06-01)

Dose and Efficacy of Bevacizumab in Recurrent High-Grade Gliomas: A Retrospective Study
Bằng: Bai X, et al.
Được phát hành: (2024-11-01)

Bevacizumab in recurrent WHO grades II–III glioma
Bằng: Soufyan Annakib, et al.
Được phát hành: (2023-07-01)

Durable Complete Remission of a Brainstem Glioma Treated with a Combination of Bevacizumab and Cetuximab
Bằng: Joan Manel Gasent Blesa, et al.
Được phát hành: (2012-12-01)

BEVACIZUMAB IN COMBINATION WITH IRINOTECAN IN THE TREATMENT OF RECURRENT GLIOBLASTOMAS
Bằng: D. R. Naskhletashvili, et al.
Được phát hành: (2015-04-01)

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
Bằng: Mesti Tanja, et al.
Được phát hành: (2015-03-01)

Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma
Bằng: Moire Cuncannon, et al.
Được phát hành: (2019-05-01)

The efficacy and adverse events of bevacizumab combined with temozolomide in the treatment of glioma: a systemic review and meta-analysis of randomized controlled trials
Bằng: SiYao Wei, et al.
Được phát hành: (2024-07-01)

Mechanism and significance of diffusion restriction followed by calcification in high-grade glioma treated with bevacizumab
Bằng: Tomohiro Hosoya, et al.
Được phát hành: (2024-11-01)

Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells
Bằng: Mesti Tanja, et al.
Được phát hành: (2018-11-01)

Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma
Bằng: N. García-Romero, et al.
Được phát hành: (2020-06-01)

CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma
Bằng: Masahiro Nishikawa, et al.
Được phát hành: (2021-03-01)

Cost-effectiveness analysis of bevacizumab combined with lomustine in the treatment of progressive glioblastoma using a Markov model simulation analysis
Bằng: Zhaoyan Chen, et al.
Được phát hành: (2024-05-01)

Daily functioning in glioma survivors: associations with cognitive function, psychological factors and quality of life
Bằng: Kathleen Van Dyk, et al.
Được phát hành: (2022-06-01)

Opportunities and Challenges for Successful Use of Bevacizumab in Pediatrics
Bằng: Amy eBarone, et al.
Được phát hành: (2013-04-01)

Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
Bằng: Hiroyuki Tatekawa, et al.
Được phát hành: (2021-03-01)

Bevacizumab is associated with cerebral microstructural alterations: a DTI study in high-grade glioma
Bằng: Rebecca Kassubek, et al.
Được phát hành: (2023-05-01)

Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis
Bằng: Celina Bihan, et al.
Được phát hành: (2012-09-01)

Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma
Bằng: Eudocia Q. Lee, et al.
Được phát hành: (2019-10-01)

Use of bevacizumab in pediatric low-grade glioma: Ten-year experience in a single center
Bằng: Margarida Simão-Rafael, et al.
Được phát hành: (2023-12-01)

Association between lesion location and language function in adult glioma using voxel-based lesion-symptom mapping
Bằng: Pia Banerjee, et al.
Được phát hành: (2015-01-01)

Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine
Bằng: Ramon F. Barajas, et al.
Được phát hành: (2016-10-01)

Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series
Bằng: George Ansstas, et al.
Được phát hành: (2016-01-01)

Differential expression of the circadian clock network correlates with tumour progression in gliomas
Bằng: Marina Petkovic, et al.
Được phát hành: (2023-07-01)

Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
Bằng: Barbara Castelli, et al.
Được phát hành: (2023-09-01)

The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
Bằng: Giovanni Luca Gravina, et al.
Được phát hành: (2017-01-01)

Survival prediction using apparent diffusion coefficient values in recurrent glioblastoma under bevacizumab treatment: an updated systematic review and meta-analysis
Bằng: Dong Liu, et al.
Được phát hành: (2024-07-01)

Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
Bằng: Barbara Castelli, et al.
Được phát hành: (2024-02-01)

Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab
Bằng: Samy Ammari, et al.
Được phát hành: (2021-07-01)

Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review
Bằng: Oguz Ozel, et al.
Được phát hành: (2016-08-01)

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma
Bằng: Emil Lou, et al.
Được phát hành: (2013-04-01)

Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma
Bằng: Seung Won Choi, et al.
Được phát hành: (2018-05-01)

Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map
Bằng: Minjie Fu, et al.
Được phát hành: (2023-06-01)

Circadian Alterations in a Murine Model of Hypothalamic Glioma
Bằng: José M. Duhart, et al.
Được phát hành: (2017-10-01)

Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell lines
Bằng: Valerie J. Marallano, et al.
Được phát hành: (2024-03-01)

Selected cytostatic drugs in the treatment of brain glioma – literature review
Bằng: Jarosław Bała, et al.
Được phát hành: (2021-11-01)

Bevacizumab combined with re-irradiation in recurrent glioblastoma
Bằng: Lei She, et al.
Được phát hành: (2022-08-01)

A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy
Bằng: Shanmu Jin, et al.
Được phát hành: (2024-03-01)